PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 5 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Oral administration of scillascilloside D-2 (6) reduced serum triglyceride levels in a dose-dependent manner in soybean oil-loaded mice [PMID:33514028].
Evidence summary
PubMed sources
- 1.PMID: 33514028 (2021) — Chemical Constituents of the Bulbs of Scilla peruviana and Their Pancreatic Lipase Inhibitory Activity. · International journal of molecular sciences
- 2.PMID: 15165148 (2004) — Glycosidase-inhibiting pyrrolidines and pyrrolizidines with a long side chain in Scilla peruviana. · Journal of natural products
- 3.PMID: 30743531 (2011) — First Report of Embellisia hyacinthi Causing a Leaf Spot and Bulb Skin Spot Disease on Scilla peruviana in California. · Plant disease
- 4.PMID: 8149459 (1994) — Lanosterol oligosaccharides from the plants of the subfamily Scilloideae and their antitumor-promoter activity. · Chemical & pharmaceutical bulletin